CLOPIDROGEL – HISTORIC AND MODERN BASIS OF ANTI-PLATELET THERAPY OF ACS

Abstract

Modern antithrombotic drugs have quick and intense inhibiting action on thrombocyte aggregation as compared to clopidrogel. Ticagrelor, prasugrel or clopidrogel might be used for therapy of patients with acute coronary syndrome. But clopidrogel still remains a drug of choice for acute coronary syndrome patients who underwent transcutaneous coronary intervention with preceding thrombolysis or in patients simultaneously receiving anticoagulants.

Keywords

• острый коронарный синдром
• антитромботическая терапия
• клопидогрел
• тикагрелор
• прасугрел